Differences between normal and CML stem cells: potential targets for clinical exploitation.

Stem cells (Dayton, Ohio)

Volumn 16 Suppl 1, Issue , 1998, Pages 77-83

  Eaves, A C ^a   Barnett, M J ^a   Ponchio, L ^a   Cashman, J D ^a   Petzer, A L ^a   Eaves, C J ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BLOOD; CHRONIC MYELOID LEUKEMIA; CLONOGENIC ASSAY; CYTOLOGY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MOUSE; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PATHOLOGY; REFERENCE VALUE; REVIEW; XENOGRAFT;

ANIMALS; COLONY-FORMING UNITS ASSAY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MICE; MICE, INBRED NOD; MICE, SCID; REFERENCE VALUES; TRANSPLANTATION, HETEROLOGOUS;

MLCS; MLOWN;

EID: 0032227733     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.5530160809     Document Type: Review

References (26)